Investors/Epidarex Capital

2 London Mempool companies backed by Epidarex Capital

Rank =208 of 430 on the investor leaderboard. A source says it led a round in 1 of them.

See them on the mapCounts only deals named in a source we fetched

Inner London. Coloured dots are the portfolio, grey dots the rest of the map.

Portfolio by sector

Health22 Health companies

Portfolio on the map (2)

Epsilogen
Develops IgE, IgA and IgG antibody therapeutics for cancer, with lead candidate MOv18 IgE in a Phase Ib trial in platinum-resistant ovarian cancer.
Health · Cancer antibodies · Up and coming
source: samedanltd.com
Leucid Bio
King's College London spinout developing Lateral CAR-T cell therapies for solid tumours, now in a Phase I/IIa trial.
Health · CAR-T Therapy · Up and comingLed a round
source: leucid.com

We list Epidarex Capital on a company only when a page we fetched names it as an investor. Its real London portfolio is likely bigger. Know a deal we missed? Suggest a fix with a source. How we count